Filing Details

Accession Number:
0001615774-18-005289
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-14 16:05:43
Reporting Period:
2018-06-14
Accepted Time:
2018-06-14 16:05:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1430306 Tonix Pharmaceuticals Holding Corp. TNXP Pharmaceutical Preparations (2834) 261434750
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1668150 Bradley Saenger C/O Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York NY 10022
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2018-06-14 300 $4.10 3,079 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct